| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2000 | CN1240137A Method for processing lentinan protein |
| 01/05/2000 | CN1240136A Medicine for promoting growth of vagina gram-positive bacillus and increasing vagina acidity and usage thereof |
| 01/05/2000 | CN1240135A Compound preparation for curing acne |
| 01/05/2000 | CN1240134A Nose added medicinal preparation for curing sexual function disturbance |
| 01/05/2000 | CN1240132A Controlled release formulation |
| 01/05/2000 | CN1048017C Novel phosphonocarboxylate compounds and pharmaceutical compositions containing same |
| 01/05/2000 | CN1048015C Bicyclic tetrahydro pyrazolopyridines |
| 01/05/2000 | CN1048014C Substituted pyrroles compound and preparational process, medicinal compositions and use |
| 01/05/2000 | CN1047949C Niuhunnggongjing powder medicine and preparation process |
| 01/05/2000 | CN1047944C Traditional Chinese medicinal capsule for curing chronic hepatitis |
| 01/05/2000 | CN1047936C Method for producing pharmaceutical composite containing alkylmelatonins |
| 01/05/2000 | CN1047935C Direct compression cholestry ramine tablet and solvent-free coating thereof |
| 01/05/2000 | CN1047934C Compound lysinpirinum nose drops and preparing process thereof |
| 01/05/2000 | CN1047932C Dental floss for health care of teeth and mouth cavity |
| 01/04/2000 | US6011166 Trinuclear cationic platinum complexes having antitumor activity and pharmaceutial compositions containing them |
| 01/04/2000 | US6011159 Processes and intermediates for preparing substituted indazole derivatives |
| 01/04/2000 | US6011148 Methods for purifying nucleic acids |
| 01/04/2000 | US6011142 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6011071 Ether compound and process for producing the same |
| 01/04/2000 | US6011070 Slow-onset, long-lasting dopamine reuptake blockers |
| 01/04/2000 | US6011069 Multidrug resistance inhibitors |
| 01/04/2000 | US6011068 Carbocyclic-alkyl secondary amines |
| 01/04/2000 | US6011067 The combination of l-glutathione and selenium that acts as its synergistic co-partner, both incorporated in a suitable topical carrier. |
| 01/04/2000 | US6011066 Method for treating septic shock |
| 01/04/2000 | US6011063 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/04/2000 | US6011062 Polyethoxylated castor oil |
| 01/04/2000 | US6011060 Treating a disease mediated by activation of the tumor necrosis factor |
| 01/04/2000 | US6011059 Acyl guanidine sodium/proton exchange inhibitors and method |
| 01/04/2000 | US6011057 Methods for inhibiting uterine fibroid disease |
| 01/04/2000 | US6011055 Administering indomethacin, naproxen, ibuprofen, tenidap and imiquod in a pharmacologically acceptable carrier, excipient or diluent. |
| 01/04/2000 | US6011054 Method for treating depression, obsessive compulsive disorder, and anxiety with N--acetyl serotonin |
| 01/04/2000 | US6011053 Substituted indole-1-carbothioic acid amides as novel antiatherosclerotic agents |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6011049 Combinations for diabetes |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011044 Antiulcer agents |
| 01/04/2000 | US6011043 Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
| 01/04/2000 | US6011040 Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 01/04/2000 | US6011037 Thiazole derivatives with phosphodiesterase-inhibiting action |
| 01/04/2000 | US6011035 Libraries of these compounds can also be used to identify antagonists for other targets. compounds containing benzhydril and 6-membered heterocyclic moieties |
| 01/04/2000 | US6011032 Heterocyclic compounds for treating myocardial ischemia |
| 01/04/2000 | US6011030 Method of treating symptoms of microbial infection or sepsis |
| 01/04/2000 | US6011029 Benzodiazepine compounds |
| 01/04/2000 | US6011028 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 01/04/2000 | US6011027 Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans |
| 01/04/2000 | US6011026 P-(aminoalkoxyphenyl)-steroid derivative |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/04/2000 | US6011024 Steroid sulphatase inhibitors |
| 01/04/2000 | US6011023 Angiostatic steroids |
| 01/04/2000 | US6011022 Topical application of muscarinic analgesic drugs such as neostigmine |
| 01/04/2000 | US6011021 Glutamate-derived hydroxyphosphinyl derivative. |
| 01/04/2000 | US6011019 Vasoactive effects and free radical generation by β-amyloid peptides |
| 01/04/2000 | US6011017 Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass |
| 01/04/2000 | US6011000 Hematopoietic protein or a positive hemoglobin modulating agent and either thiophenoxyacetic acid, thiophenoxypropionic acid, thiophenoxybutyric acid, ethyl butyrate, a dihydrocinnamic acid or pharmaceutically acceptable salts |
| 01/04/2000 | US6010906 Antisense modulation of Jun N-terminal kinase kinase-1 expression |
| 01/04/2000 | US6010895 Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010846 Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
| 01/04/2000 | US6010718 Extended release formulations of erythromycin derivatives |
| 01/04/2000 | US6010716 Containing fatty or alcohol absorption promoter |
| 01/04/2000 | US6010706 Container for ascorbic acid composition |
| 01/04/2000 | US6010692 Method and composition for preventing surgical adhesions and tissue damage |
| 01/04/2000 | US6010685 Skin protectant comprising 5-substituted and 5,5-disubstituted 3,4-dihydroxy-2(5H)-furanones |
| 01/04/2000 | US6009875 Use of sympathetic antagonists for treatment of chronic muscle pain |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 01/04/2000 | CA2118172C Galanthamine derivatives, a process for their preparation and their use as medicaments |
| 01/04/2000 | CA2104474C Compositions and methods for topical administration of pharmaceutically active agents |
| 01/04/2000 | CA2029537C Pradimicin derivatives |
| 01/04/2000 | CA2029368C Injectable solution and process for preparing same |
| 01/04/2000 | CA2025790C New lipidic compositions derivated from spingosins, process for their preparation and uses, especially as cosmetics and dermatologic agents |
| 01/04/2000 | CA2022848C Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 01/03/2000 | CA2276902A1 Cosmetic compositions, new anti-elastase ceramide analogs, preparation process and uses |
| 01/02/2000 | CA2269999A1 Novel compound |
| 01/01/2000 | CA2276984A1 Cyclooxygenase inhibitor |
| 12/30/1999 | DE19859668A1 Treating or preventing viral, bacterial, fungal or parasitic infections using bis-phosphonic acid compounds, also having herbicidal activity |
| 12/30/1999 | DE19828979A1 Analgesic therapy by patient-controlled oral administration of opioids |
| 12/30/1999 | DE19828463A1 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen 4,4-diarylbutadienes as water-soluble photostable UV filters for cosmetic and pharmaceutical preparations |
| 12/30/1999 | DE19828450A1 Use of bisphosphonic acid compounds and autoantigens or allergens |
| 12/30/1999 | DE19828274A1 Transdermal patch for controlled release of estradiol and norethisterone acetate with reservoir based on polyacrylate adhesive and containing terpolymer crystallization inhibitor |
| 12/30/1999 | DE19828273A1 Transdermal patch useful for controlled release of estradiol and norethisterone acetate |
| 12/30/1999 | DE19828068A1 Treating bone resorption disease, especially osteoporosis, using specific osteoclast inhibitors |
| 12/30/1999 | DE19827907A1 Synergistic composition for treating infant or adult respiratory distress syndrome |
| 12/30/1999 | CA2276564A1 Modified c1 esterase inhibitor for blocking the infectiousness of hiv |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067809A1 Compositions and methods for inhibiting bone resorption |
| 12/29/1999 | WO1999067430A2 Analytic substrates and antioxidative agents |
| 12/29/1999 | WO1999067417A2 Fitness assay and associated methods |
| 12/29/1999 | WO1999067408A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067388A1 Antisense oligonucleotide inhibiting the expression of il-10 protein |
| 12/29/1999 | WO1999067379A2 Structured antisense nucleic acid molecules |
| 12/29/1999 | WO1999067296A1 Polymers for delivering nitric oxide in vivo |
| 12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 12/29/1999 | WO1999067276A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 12/29/1999 | WO1999067275A1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 12/29/1999 | WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067273A1 Meiosis regulating compounds |
| 12/29/1999 | WO1999067272A1 A compound, wf002, production thereof and use thereof |